FDA Grants AP Status for Haloperidol Decanoate ANDA214507
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Haloperidol Decanoate submitted by Meitheal.
Asset / Drug
Drug and asset intelligence for Meitheal with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Proton Pump Inhibitor
No catalysts indexed for this entity yet.
Monitor the launch timeline and market entry strategies of Meitheal for Haloperidol Decanoate.
July 1, 2026 · N/A
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.